Lightnews — Scholar-powered news

Reposted by Christopher Graber

IDSA @idsainfo.bsky.social · 4d

On IDSA’s & HIVMA’s Science Speaks blog: Christopher J. Graber, MD, MPH, FIDSA, explores dalbavancin versus standard therapy for completion of treatment of complicated S. aureus bacteremia. https://bit.ly/4ncqnAt

DOT-ting i's and crossing t's: More evidence for using long-acting glycopeptides to finish therapy of complicated S. aureus bacteremia

A JAMA study looked at dalbavancin versus standard therapy for completion of treatment of complicated S. aureus bacteremia. Read IDSA's Journal Club review.

www.idsociety.org

2 6

Christopher Graber @idsensei.bsky.social · 16d

1

Christopher Graber @idsensei.bsky.social · 21d

Looking to do some stewardship and/or hospital epi? Join me, @wbranchelliman.bsky.social, and our crew at VA Greater Los Angeles!

1 1 5

Christopher Graber @idsensei.bsky.social · 27d

best admin assistant (and pre-interview Zoom DJ) ever!

UCLA Department of Medicine @domucla.bsky.social · 27d

Meet Claire Echeverri, administrative assistant in the division of infectious diseases. From managing schedules to supporting fellows and faculty, her adaptability and professionalism keep the division running smoothly. Learn more about Claire here: uclahs.fyi/4m9qGLT

3

Reposted by Christopher Graber

Tara Vijayan @nottheogdrv.bsky.social · Sep 3

Colleagues- in case this was missed during summer vacation, please share. I just went to the Bowl again last week and saw Yo-Yo Ma and Angelique Kidjo. The Bowl is not the only reason to be in LA....but it is pretty spectacular. Also my ASP team is just the bee's knees.

Tara Vijayan @nottheogdrv.bsky.social · Jun 13

Please consider joining our incredible faculty and ASP program at UCLA Health. Los Angeles is an incredible city and always will be. recruit.apo.ucla.edu/JPF10331

1 2

Christopher Graber @idsensei.bsky.social · Aug 13

Calling it a showdown would be vastly overstating it. Fun article that notes differences in cocci presentations in CA vs AZ that we think are driven by inherent population and care pattern differences and not anything inherent to immitis vs posadasii

academic.oup.com/ofid/article...

Comparison of Patients With Coccidioidomycosis in Arizona Versus California: A Commercial Health Insurance Claims Analysis

Abstract. Commercially insured patients with coccidioidomycosis in Arizona (n = 1640) were more likely to have symptoms indicating acute pulmonary disease

academic.oup.com

1

Christopher Graber @idsensei.bsky.social · Aug 12

the marker of a good journal club is that the fellows have already left for clinic and the attendings are still arguing

1 5

Christopher Graber @idsensei.bsky.social · Aug 9

I demand a randomized controlled trial of hiring people who resign back to their prior jobs. The public deserves nothing less.

Helen Branswell 🇨🇦 @helenbranswell.bsky.social · Aug 9

Big news: Vinay Prasad is returning to #FDA as head of the center for biologics, @lizzylawrence.bsky.social reports. www.statnews.com/2025/08/09/v...

Vinay Prasad returns to the FDA, weeks after his ouster

HFO HFO Vinay Prasad returns to a top FDA role just weeks after his abrupt dismissal.

www.statnews.com

2

Christopher Graber @idsensei.bsky.social · Aug 4

Moderate immunocompromise (even if overly broadly defined) should not buy you vanc + antipseudomonal for CAP: my latest @idsainfo.bsky.social Journal Club review:

www.idsociety.org/science-spea...

Broad-spectrum antibiotics for moderately immunocompromised patients with CAP: An overdone practice

A study in CID examined broad-spectrum antibiotics in moderately immunocompromised patients with community-acquired pneumonia

www.idsociety.org

5 12

Christopher Graber @idsensei.bsky.social · Aug 1

my fellow just put up a slide in case conference with the “distracted boyfriend” meme for linezolid overtaking clindamycin as the “toxin” drug of choice and never have I been more proud as a program director

2

Christopher Graber @idsensei.bsky.social · Jul 31

let’s goooooooooooooo

IDWeek @idweek.bsky.social · Jul 29

Coming soon to an IDWeek near you... 👀

Register today for #IDWeek2025 before rates increase this Saturday, Aug. 2: idweek.org/registration

1

Christopher Graber @idsensei.bsky.social · Jul 22

we’ve all been there, right?

6

Christopher Graber @idsensei.bsky.social · Jul 18

most men aren’t complicated, it turns out (at least as it pertains to UTI)

IDSA @idsainfo.bsky.social · Jul 17

🚨 IDSA has released the first guidelines for the management and treatment of complicated urinary tract infections (cUTIs)!

The new guidelines simplify the prior definitions of uncomplicated UTIs and cUTIs, & address treatment for cUTIs.

View guidelines: bit.ly/4lUjN1a

2 1 7

Christopher Graber @idsensei.bsky.social · Jul 10

you’re damn right I’m giving feedback on every internal medicine LKA question I miss as being a bad question

6

Christopher Graber @idsensei.bsky.social · Jul 8

good reminder for all the new trainees: antibiotics don’t fix structural abnormalities

1

Christopher Graber @idsensei.bsky.social · Jul 6

ID is about so much more than picking the correct antibiotics

Tara Vijayan @nottheogdrv.bsky.social · Jul 5

There are many important perspectives and ideas to share in medicine at this moment that are more important than mine. But this is a reminder of why I keep doing what I do, despite everything. I would be honored if you took the time to read it. www.nejm.org/doi/full/10....

Libraries Burned, a Life Lived | NEJM

As her patients near the end of life, an infectious disease physician who knows their stories sometimes needs to step out of her proverbial lane to help them assess and achieve their goals of care.

www.nejm.org

1 3

Reposted by Christopher Graber

IDSA @idsainfo.bsky.social · Jul 2

On IDSA’s & HIVMA’s Science Speaks blog: A study in OFID examined the impact of antibiotic duration on gut microbiome composition and antimicrobial resistance. Read IDSA’s Journal Club review by Christopher J. Graber, MD, MPH, FIDSA. buff.ly/CDwwOlf

Shorter may be better, but how (and how much better)?

A study in OFID examined the impact of antibiotic duration on gut microbiome composition and antimicrobial resistance.

www.idsociety.org

1 1 4

Christopher Graber @idsensei.bsky.social · Jun 27

IDSA Journal Club is back, baby! My latest on the perhaps questionable effect of shortening antimicrobial courses of therapy on the gut microbiome:

www.idsociety.org/science-spea...

Shorter may be better, but how (and how much better)?

A study in OFID examined the impact of antibiotic duration on gut microbiome composition and antimicrobial resistance.

www.idsociety.org

1 3

Christopher Graber @idsensei.bsky.social · Jun 8

you and I prepare for talks differently…this morning on my run I decided that my fellowship graduation speech is going to involve a story about how Michael Stipe came up with lyrics for an R.E.M. deep album cut from 1991 and a YouTube video involving a honey badger and I’m gonna wing it from there

1 2

Reposted by Christopher Graber

IDSA @idsainfo.bsky.social · May 5

Deadline approaching! Submit your team of ID trivia powerhouses to compete in IDBugBowl, a Jeopardy-style competition held at #IDWeek2025: buff.ly/JUFUcel

IDWeek will pay FULL conference registration for student, resident & fellow team participants.

Apply by 5/16.

1

Reposted by Christopher Graber

UCLA Multicampus Fellowship in Infectious Diseases @ucla-id-fellowship.bsky.social · Apr 28

It takes a village! So many past/present/future fellows on this paper examining Karius utilization: most clinical impact seen with cx neg IE and concern for fastidious/zoonotic/vectorborne pathogens

www.cambridge.org/core/journal...

Real-world clinical impact of plasma cell-free DNA metagenomic next-generation sequencing assay | Infection Control & Hospital Epidemiology | Cambridge Core

Real-world clinical impact of plasma cell-free DNA metagenomic next-generation sequencing assay - Volume 46 Issue 5

www.cambridge.org

1 3

Christopher Graber @idsensei.bsky.social · Apr 26

get those applications in!

ID BugBowl @idbugbowl.bsky.social · Apr 26

Test your ID knowledge at #IDWeek2025 and apply to participate in one of our most popular events! All student, resident and fellow participants on each team selected for #IDBugBowl will have their conference registration paid for by IDWeek.

Apply: idweek.org/events/bugbowl/

1 2

Christopher Graber @idsensei.bsky.social · Apr 24

I said stopping antibiotics on a CABG patient POD 3 with a modest leukocytosis

1

Christopher Graber @idsensei.bsky.social · Apr 24

so I am starting to bring up lessons I have learned from Dan Campbell (Detroit Lions coach) in talks on leadership in antimicrobial stewardship. Question from a colleague: What is the ASP equivalent of going for it on 4th down?

2 2

Christopher Graber @idsensei.bsky.social · Apr 21

was discussing the vagaries of diagnosing osteomyelitis in conference today as to whether osteo was bona fide or not and someone said “don’t you mean bony fide” so that’s what I’m calling it now

4